Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.Still think they have any idea what an effective supplement is?
Results from the decade-long study, initiated by the Eastern Cooperative Oncology Group, were presented at the American Society of Clinical Oncology 2010 Annual Meeting by Daniel D. Karp, M.D., professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center.
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Thursday, June 24, 2010
No Benefit In Prevention Of Lung Cancer In Clinical Trial Of Selenium
Oops.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.